Grace Link Barnes

Research Associate

1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Grace Link Barnes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Tuberculosis Medicine & Life Sciences
rifapentine Medicine & Life Sciences
HIV Medicine & Life Sciences
Isoniazid Medicine & Life Sciences
Malawi Medicine & Life Sciences
Latent Tuberculosis Medicine & Life Sciences
Viral Load Medicine & Life Sciences
CD4 Lymphocyte Count Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Malawi
Microscopy
Tuberculosis
HIV
Point-of-Care Systems

Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi

Ngwira, L. G., Dowdy, D. W., Khundi, M., Link Barnes, G., Nkhoma, A., Choko, A. T., Murowa, M., Chaisson, R. E., Corbett, E. L. & Fielding, K., Mar 1 2018, In : International Journal of Tuberculosis and Lung Disease. 22, 3, p. 280-286 7 p.

Research output: Contribution to journalArticle

Malawi
Tuberculosis
HIV
Health
Poverty

Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi

Little, K. M., Khundi, M., Link Barnes, G., Ngwira, L. G., Nkhoma, A., Makombe, S., Corbett, E. L., Chaisson, R. E. & Dowdy, D. W., Apr 1 2018, In : International Journal of Tuberculosis and Lung Disease. 22, 4, p. 371-377 7 p.

Research output: Contribution to journalArticle

Malawi
Isoniazid
HIV
Therapeutics
Tuberculosis

Factors associated with pulmonary impairment in HIV-infected South African adults

Gupte, A. N., Wong, M. L., Msandiwa, R., Link Barnes, G., Golub, J. E., Chaisson, R. E., Hoffmann, C. & Martinson, N. A., Sep 1 2017, In : PLoS One. 12, 9, e0184530.

Research output: Contribution to journalArticle

Obstructive Lung Diseases
Pulmonary diseases
respiratory tract diseases
lungs
HIV

A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis

Conde, M. B., Mello, F. C. Q., Duarte, R. S., Cavalcante, S. C., Rolla, V., Dalcolmo, M., Loredo, C., Durovni, B., Armstrong, D. T., Efron, A., Link Barnes, G., Marzinke, M. A., Savic, R. M., Dooley, K. E., Cohn, S., Moulton, L. H., Chaisson, R. E. & Dorman, S. E., May 1 2016, In : PLoS One. 11, 5, e0154778.

Research output: Contribution to journalArticle

rifapentine
Pulmonary Tuberculosis
tuberculosis
lungs
isoniazid